|
Includes all of these presentations from this session:
| # |
Presentation |
Speaker |
| 1 |
How was the Cancer Genome Atlas was developed and how is it being used? |
A. Boussioutas (Melbourne) |
| 2 |
How was COSMIC developed and how is it being used? |
D.G. Beer (Ann Arbor) |
| 3 |
How useful is tumour analysis? |
A. Barbour (Brisbane) |
| 4 |
How is the UK Barretts Registry run and used? |
C. Caygill (London) |
| 5 |
What databases and systems are based at NCI? |
D. Seminara (Bethesda) |
| 6 |
How is the Mayo Clinic Esophageal Adenocarcinoma and Barrett?s Esophagus (EABE) Registry curated and how is it used? |
Y. Romero (Rochester, MN) |
| 7 |
What is the role of p53 database in cancer? |
D. Kandioler (Vienna) |
| 8 |
How will genetic data from the Linxian Cancer Prevention Study prevent cancer? |
C.C. Abnet (NCI Bethesda) |
| 9 |
What software is available for curation of variation databases? |
M. Vihinen (Lund) |
| 10 |
What is the value of association studies in Barretts? |
Y. Romero (Rochester, MN) |
| 11 |
What is the role of epigenetics in cancer? |
N.S. Buttar (Rochester) |
| 12 |
What is ideal way of coordinating collection and analysis of genomic data? |
Xifeng Wu (Houston) |
|
